These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16567126)

  • 1. Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.
    van Veldhuisen DJ; Aass H; El Allaf D; Dunselman PH; Gullestad L; Halinen M; Kjekshus J; Ohlsson L; Wedel H; Wikstrand J;
    Eur J Heart Fail; 2006 Aug; 8(5):539-46. PubMed ID: 16567126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery.
    Halonen J; Hakala T; Auvinen T; Karjalainen J; Turpeinen A; Uusaro A; Halonen P; Hartikainen J; Hippeläinen M
    Circulation; 2006 Jul; 114(1 Suppl):I1-4. PubMed ID: 16820555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate control in patients with chronic atrial fibrillation and heart failure.
    Silvet H; Hawkins LA; Jacobson AK
    Congest Heart Fail; 2013; 19(1):25-8. PubMed ID: 22958623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative prophylaxis can decrease rates of atrial fibrillation in open heart surgery: a retrospective study.
    Koçoğullari CU; Emmiler M; Ayva E; Sasirtan T; Eren N; Cekirdekci A
    Heart Surg Forum; 2008; 11(3):E159-63. PubMed ID: 18583286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease.
    Raunsø J; Pedersen OD; Dominguez H; Hansen ML; Møller JE; Kjaergaard J; Hassager C; Torp-Pedersen C; Køber L;
    Eur J Heart Fail; 2010 Jul; 12(7):692-7. PubMed ID: 20403817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
    Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
    Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction.
    Asanin M; Perunicic J; Mrdovic I; Matic M; Vujisic-Tesic B; Arandjelovic A; Vasiljevic Z; Ostojic M
    Eur J Heart Fail; 2005 Jun; 7(4):671-6. PubMed ID: 15921810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction.
    Corell P; Gustafsson F; Schou M; Markenvard J; Nielsen T; Hildebrandt P
    Eur J Heart Fail; 2007 Mar; 9(3):258-65. PubMed ID: 17027330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure.
    Wasywich CA; Whalley GA; Gamble GD; Wright SP; Doughty RN
    Heart Lung Circ; 2006 Dec; 15(6):353-7. PubMed ID: 17046323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups].
    Sidorenko BA; Bugrimova MA; Iosava IK; Pataraia SA; Preobrazhenskiĭ DV
    Kardiologiia; 2008; 48(3):85-8. PubMed ID: 18429761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate- vs extended-release metoprolol in heart failure.
    Huneycutt B
    J Fam Pract; 2003 Aug; 52(8):635-6; author reply 636. PubMed ID: 12899820
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Hillege HL; Van Veldhuisen DJ
    Int J Cardiol; 2006 Apr; 109(1):95-100. PubMed ID: 15993501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study.
    Connolly SJ; Cybulsky I; Lamy A; Roberts RS; O'brien B; Carroll S; Crystal E; Thorpe KE; Gent M;
    Am Heart J; 2003 Feb; 145(2):226-32. PubMed ID: 12595838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.